AnalystsSalim Syed
Salim Syed's Stock Forecasts

Analyst Ranking
Bottom 7%
#4830 out of 5156 analysts
Average Return
-4.87%
Win Rate
39%24 out of 62
Risk vs Reward
Poor
Good

Salim Syed's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Nkarta IncNKTX
+149.75%$1.99$4.97
2023-08-13 -
2024-08-13
Strong Buy
Bridgebio Pharma IncBBIO
+149.26%$11.47$28.59
2022-08-23 -
2023-08-23
Strong Buy
Bridgebio Pharma IncBBIO
+105.55%$13.52$27.79
2023-05-07 -
2024-05-07
Strong Buy
Cytokinetics IncCYTK
+91.00%$31.32$59.82
2025-05-28 -
2025-12-17
Buy
Bridgebio Pharma IncBBIO
+89.59%$35.17$66.68
2020-02-18 -
2021-02-19
Strong Buy

Salim Syed's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Incyte CorpINCY
1Buy$121.00+23.94%Upgrades
11 days ago
Assembly Biosciences IncASMB
2Buy$40.00+22.77%Maintains
a month ago
Nkarta IncNKTX
8Buy$14.00+690.96%Maintains
6 months ago
Cytokinetics IncCYTK
6Buy$84.00+40.42%Maintains
7 months ago
Biogen IncBIIB
14Buy$169.00-1.80%Maintains
7 months ago
Amgen IncAMGN
6Hold$280.00-14.11%Maintains
7 months ago
Gilead Sciences IncGILD
6Buy$117.00-3.59%Maintains
7 months ago
Wave Life Sciences LtdWVE
5Buy$22.00N/AMaintains
a year ago
Vaxcyte IncPCVX
3Buy$163.00N/AMaintains
a year ago
Atara Biotherapeutics IncATRA
4Buy$18.00N/AUpgrades
a year ago
Enliven Therapeutics IncELVN
1Strong Buy$34.00N/AInitiates Coverage On
2 years ago
Crispr Therapeutics AgCRSP
3Strong Buy$99.00N/AMaintains
2 years ago
Bridgebio Pharma IncBBIO
7Strong Buy$53.00N/AMaintains
2 years ago
Unity Biotechnology IncUNBX
5Strong Buy$6.00N/AMaintains
3 years ago
Coherus Oncology IncCHRS
3Strong Buy$21.00N/AMaintains
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.